SPERO
Biotechnology Research • 
CRScube Inc. 4F, 19, Korea, Republic of • 1-10 Employees
Company overview
| Headquarters | CRScube Inc. 4F, 19, Yanghwa-ro, Mapo-gu, Seoul, Rep. of Korea, Seoul, Seoul, 04027, KR |
| Website | |
| NAICS | 541714 |
| Keywords | Medical Writing, Project Management, Econsent, Centralized Monitoring, Decentralized Clinical Trials, Site Monitoring |
| Founded | 2018 |
| Employees | 1-10 |
Key Contact at SPERO
Minwhan Choi
Marketing Director
SPERO Email Formats
SPERO uses 1 email format. The most common is {first initial}.{last name} (e.g., j.doe@ispero.io), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@ispero.io | 100% |
About SPERO
Clinical trial operation & eClinical solution service [Specialized Areas] - Medical Writing - Clinical Trial Project Management & Site monitoring : based on the VIA centralized monitoring system - Patient Recruitment solution MediCLEO - eConsent service (Approx. 80+ IRB approvals in Korea and Japan)
$
SPERO revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Funding Data
SPERO has never raised funding before.
United States
Denmark
United Kingdom
Canada
Italy
AustraliaFrequently asked questions
SPERO is located in CRScube Inc. 4F, 19, KR.
SPERO was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.
SPERO has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
